REQUEST A DEMO
总计
USD $0.00
搜索更多公司

Universe Pharmaceuticals Inc. (中国)

主营业务: 医药制剂制造 | 健康和个人护理店
全名: Universe Pharmaceuticals Inc. 公司更新日期: 2024.03.15
购买我们的报告为这家公司 USD 29.95 最近财务数据:2023 可有的: 英语 & 中文 下载示例的报告

Universe Pharmaceuticals Inc is a pharmaceutical company that specializes in manufacturing, selling, and distributing traditional Chinese medicine derivatives (TCMD) products. They focus on addressing the physical conditions of the elderly and promoting their general well-being. The company has registered and obtained approval for 26 varieties of TCMD products and currently produces 13 varieties, which are sold in approximately 202 cities of 30 provinces in China. Their major customers are pharmaceutical companies, hospitals, clinics, and drugstore chains primarily located in various provinces in China. They also distribute and sell products manufactured by third-party producers, including biomedical drugs, medical instruments, TCMPs, and dietary supplements. Their products fall into two categories: treatment and relief for common chronic health conditions in the elderly (Chronic Condition Treatments) and cold and flu medications.

总部
265 Jingjiu Avenue, Jinggangshan Economic And Technological Development Zone
吉安; 江西; 邮编: 343100

联系方式: 购买Universe Pharmaceuticals Inc.报告以查看信息。

网站: http://www.universe-pharmacy.com

基本信息
员工总数:
购买Universe Pharmaceuticals Inc.报告以查看信息。
流通股:
购买Universe Pharmaceuticals Inc.报告以查看信息。
财务审计师:
购买Universe Pharmaceuticals Inc.报告以查看信息。
成立日期:
2019
主要管理人员
购买此报告以查看信息。
Chairman
购买此报告以查看信息。
Chief Financial Officer
购买此报告以查看信息。
Chief Operating Officer
购买此报告以查看信息。
Director/Member of the Board
购买此报告以查看信息。
Outside Director
所有权明细
购买此报告以查看信息。
57.38%
购买此报告以查看信息。
下属公司
Jiangxi Universe Pharmaceuticals Co., Ltd.
Jiangxi Universe Pharmaceuticals Commercial Trade Co., Ltd.
Jiangxi Universe Pharmaceuticals Technology Co., Ltd.
公司业绩
图表中的财务价值可在之后获得Universe Pharmaceuticals Inc.报告购买。
寻找的不仅仅是一个公司的报告吗?

EMIS公司简介是一个更大的信息服务的一部分,它结合了公司,行业和国家数据和分析在超过125个新兴市场.

请求EMIS服务的演示
主要财务重点
年增长百分比对于以当地货币近两年USD。绝对财务数据包含在购买报告中。
销售净额
-30.23%
营业收入总计
-30.23%
营业利润
未知
EBITDA
未知
净利润(亏损)
-1732.31%
总资产
-29.75%
权益总额
-43.25%
经营利润率
未知
销售收益率
-97.81%
股本收益率
-47.47%
负债股权比率
15.69%
速动比率
-0.67%
现金比率
-0.13%

查看更多信息, 申请试用

购买这家公司报告
需要定期访问公司,行业或国家/地区的信息吗?